Inovio Pharmaceuticals
INO
#9483
Rank
$0.13 B
Marketcap
$1.22
Share price
-16.21%
Change (1 day)
-43.49%
Change (1 year)

EPS for Inovio Pharmaceuticals (INO)

EPS in 2023 (TTM): -$0.65

According to Inovio Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -$1.83. In 2022 the company made an earnings per share (EPS) of -$1.18 an increase over its 2021 EPS that were of -$1.45.

EPS history for Inovio Pharmaceuticals from 1999 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$0.65-44.92%
2022-$1.18-18.62%
2021-$1.4534.26%
2020-$1.08-10.74%
2019-$1.2115.24%
2018-$1.05-0.94%
2017-$1.064.95%
2016-$1.01129.55%
2015-$0.44-29.03%
2014-$0.62-55.71%
2013-$1.40141.38%
2012-$0.5820.83%
2011-$0.48-25%
2010-$0.64-56.76%
2009-$1.4823.33%
2008-$1.2011.11%
2007-$1.08-41.3%
2006-$1.84-67.14%
2005-$5.60115.38%
2004-$2.60-62.21%
2003-$6.88186.67%
2002-$2.40-0%
2001-$2.40-21.05%
2000-$3.04-58.7%
1999-$7.36

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
$6.68-465.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
$5.25-386.89%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
$0.76-141.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
-$3.10 69.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
$0.99-154.25%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
$2.88-257.23%๐Ÿ‡ฌ๐Ÿ‡ง UK
Arrowhead Pharmaceuticals
ARWR
-$3.33 81.97%๐Ÿ‡บ๐Ÿ‡ธ USA